Reza Nejati, MD

Reza Nejati MD
This physician is not currently rated. Why?

Why is this doctor not rated?


To ensure the accuracy of our patient satisfaction scores, we require that providers who see patients receive a minimum number of completed patient-submitted surveys before their reviews are listed on their profiles. Star ratings on this site are collected on a rolling basis from the previous 12 months.
Additionally, some of the physicians listed on our site do not see patients directly, and therefore, do not receive evaluation and ratings from patients.

More about patient ratings

Associate Professor, Department of Pathology​

Medical Director of Clinical Laboratory Services

Director, Flow Cytometry Lab


Treatment Focus

Acute and Chronic Leukemias, Lymphomas, Blastic plasmacytoid dendritic cell neoplasm, Myelodysplasia, Flow Cytometry

Treatment Philosophy

I joined the pathology department at Fox Chase Cancer Center because it is a pioneer in cancer research and one of the most reputable cancer centers in the country. I am a board-certified anatomic and clinical pathologist, with sub-specialty trainings in hematopathology and oncologic surgical pathology. In hematopathology, we work very closely with a multi-disciplinary team of outstanding and dedicated clinicians and pathologists to provide the optimal patient care by continuously making precise diagnosis of cancers that affect the blood and the lymphoid systems.

Early on in my medical career, I became fascinated by cancer biology. I yearned to explore challenging fields, which had the potential for improving lives; a yearning that continues to fascinate me about pathology today. It is inspiring to see how the advancements in diagnosis, research, and treatment in this discipline are rapidly improving healthcare and patient outcomes. These prospects are exciting and as a hematopathologist, my aim is to arm clinicians with the most comprehensive diagnosis by utilizing cutting-edge technologies to provide for the most effective and up to date treatment options for patients.

Clinical Locations

Educational Background

  • Fellow, Hematopathology, University of Pennsylvania Perelman School of Medicine
  • Fellow, Oncologic Surgical Pathology, MD Anderson Cancer Center
  • Resident, Anatomic and Clinical Pathology, University of Tennessee Health Science Center
  • MD, Tehran University of Medical Sciences, Iran, 1995


American Board of Pathology, Anatomic and Clinical Pathology

American Board of Hematopathology


  • American Board of Pathology, Anatomic and Clinical Pathology American Society of Hematology (ASH)
  • American Society for Clinical Pathology (ASCP)                                           
  • College of American Pathologists (CAP)                                                       
  • United States and Canadian Academy of Pathology (USCAP)

Selected Publications

Maifrede S, Martin K, Podszywalow-Bartnicka P, Sullivan K, Langer SK, Nejati R, Dasgupta Y, Gritsyuk D, Nieborowska-Skorska M, Lupey L, Piwocka K, Wasik MA, Tempera I, and Skorski T. (in press).  IGH/MYC translocation is associated with BRCA2 deficiency and predisposed to synthetic lethality by PARP1 inhibitors. Molecular Cancer Research

Nejati R, Halperin DM,  Goldstein JB, Wang H,  Rashid A, Katz MH, Lee JE, Fleming JB, Canales JR, Blando J, Wistuba I, Maitra A, Wolff RA, Varadhachary GR  and  Wang H. (in press). The prognostic significance of infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy. Pancreas

Majors J, Stoikes NF, Nejati R, and Deneve JL. Resection and Abdominal Wall Reconstruction of a Desmoid Tumor with Endometrioma Features. Case Reports in Surgery Volume 2016, Article ID 9453450

Skobowiat C, Nejati R, Lu Lu, Williams RW, and Slominski A. Genetic variation of the cutaneous HPA axis: An analysis of UVB-induced differential responses. Gene (Journal). 2013 November; 530 (1):1-7

Nejati R, Skobowiat C, Slominski A. Commentary on the practical guide for the study of human and murine sebaceous glands. Experimental Dermatology 2013 October; 22(10):629-30